Lumbar Plexus-sciatic Nerve Block With Sevoflurane on Cognitive Function in Elderly Patients After Hip Arthroplasty
Hip Arthropathy
About this trial
This is an interventional treatment trial for Hip Arthropathy
Eligibility Criteria
Inclusion Criteria:
- Age range: 60-70 years
- American Society of Anesthesiologists (ASA) classification: Class II and class III
- Unilateral hip arthroplasty
- Educational level: Junior high school and above, no cognitive dysfunction before surgery
- Hip joint disease treatment for the first time
- All patients or family members signed the informed consent
Exclusion Criteria:
- Nervous system disease or psychosis
- Allergy to anesthesia
- Poor compliance
- Cardiovascular system disease, severe primary liver and kidney diseases
- Other diseases affecting cognitive function or cognitive dysfunction
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
the observation group
the control group
The elderly patients undergoing unilateral total hip arthroplasty will be randomized to assigned to the observation group. In the observation group, tracheal intubation will be conducted for general anesthesia after lumbar plexus-sciatic nerve block, accompanying sevoflurane inhalation for anesthesia maintenance.
The elderly patients undergoing unilateral total hip arthroplasty will be randomized to assigned to the control group. In the control group, tracheal intubation will be conducted for general anesthesia, accompanying intravenous administration of propofol for anesthesia maintenance.